Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M Früh, D De Ruysscher, S Popat, L Crinò… - Annals of …, 2013 - annalsofoncology.org
An estimated 1.6 million new lung cancers are diagnosed worldwide each year. The highest
incidence rates in males are observed in Central/Eastern and Southern Europe (57 and 49
per 100 000, respectively), whereas in women the highest rates are found in Northern
Europe (36 per 100 000)[1]. Five-year survival rates of lung cancer patients have only
slightly improved during the past decade but remain low at 10%[2]. Small-cell lung cancer
(SCLC) originates from neuroendocrine-cell precursors and is characterised by its rapid …
incidence rates in males are observed in Central/Eastern and Southern Europe (57 and 49
per 100 000, respectively), whereas in women the highest rates are found in Northern
Europe (36 per 100 000)[1]. Five-year survival rates of lung cancer patients have only
slightly improved during the past decade but remain low at 10%[2]. Small-cell lung cancer
(SCLC) originates from neuroendocrine-cell precursors and is characterised by its rapid …